Brief: Kontafarma China Sees Consolidated Net Loss Of HK$49 Mln To HK$73.6 Mln For FY 2023
11/03/2024 10:20
March 11 (Reuters) - Kontafarma China Holdings Ltd
1312.HK :
* SEES CONSOLIDATED NET LOSS OF HK$49.0 MILLION TO HK$73.6
MILLION
FOR FY 2023
* EXPECTED RESULT DUE TO DECREASE IN REVENUE, GROSS PROFIT
IN
PHARMACEUTICAL BUSINESS SEGMENT
Further company coverage: 1312.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kontafarma China Holdings
See all newsBrief: Kontafarma China Holdings Announces Creditors' Voluntary Winding-Up Of Singapore Subsidiaries
Brief: Kontafarma China Appoints Li Qingshan As Executive Director And President
Brief: Kontafarma China Sees HY Consol Net Loss Of HK$67.2 Million-HK$100.7 Million
Brief: Kontafarma China Appoints Wang Limin As Executive Director, Chairman And President
Brief: Kontafarma China Announces Resignation Of Liu Jiankun As Executive Director Effective 16 Apr